Hongsen Investment
Dr. Xu is a co-founder of Epimab Biotherapeutics. Dr. Xu had held senior scientific positions at various global world-class pharmaceutical and healthcare companies including ChemPartner, Millennium Pharmaceutical and BASF/Abbott.
Dr. Xu holds Bachelor’s and Master’s degrees in Chemistry from the Beijing University of Chemical Technology, and a PhD in Biochemistry from Brandeis University. Dr. Xu had three years of Postdoctoral training at Harvard school of Public Health in department of Cell Biology, Endocrinology and Molecular Toxicology.
This person is not in any offices
Hongsen Investment
Hongsen Investment is a strong and experienced management team, with over 100 years of collective experience in investing, biotech & healthcare, business operations and capital market experience. Hongsen Investment focuses on growing biotech companies with a strong team, proven technology, and sound business model, along with companies that have clear arbitrage and exit plans.